After finishing at $1.94 in the prior trading day, Outset Medical Inc (NASDAQ: OM) closed at $2.05, up 5.67%. In other words, the price has increased by $+0.1100 from its previous closing price. On the day, 1105711 shares were traded.
Ratios:
Our goal is to gain a better understanding of OM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.37 and its Current Ratio is at 5.26. In the meantime, Its Debt-to-Equity ratio is 1.11 whereas as Long-Term Debt/Eq ratio is at 1.10.
On January 12, 2024, RBC Capital Mkts Downgraded its rating to Sector Perform which previously was Outperform and also lowered its target price recommendation from $14 to $6.
BofA Securities Downgraded its Buy to Underperform on October 13, 2023, whereas the target price for the stock was revised from $32 to $3.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 15 ’24 when Nash Marc sold 2,391 shares for $2.13 per share. The transaction valued at 5,093 led to the insider holds 242,510 shares of the business.
Ahmed Nabeel sold 1,584 shares of OM for $4,990 on Mar 01 ’24. The Chief Financial Officer now owns 322,877 shares after completing the transaction at $3.15 per share. On Feb 15 ’24, another insider, Trigg Leslie, who serves as the Chair and CEO of the company, sold 5,320 shares for $3.57 each. As a result, the insider received 18,992 and left with 833,091 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OM now has a Market Capitalization of 104.04M and an Enterprise Value of 36.91M. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.79 while its Price-to-Book (P/B) ratio in mrq is 0.84. Its current Enterprise Value per Revenue stands at 0.28 whereas that against EBITDA is -0.24.
Stock Price History:
Over the past 52 weeks, OM has reached a high of $24.13, while it has fallen to a 52-week low of $1.94. The 50-Day Moving Average of the stock is 2.8532, while the 200-Day Moving Average is calculated to be 8.6147.
Shares Statistics:
The stock has traded on average 995.06K shares per day over the past 3-months and 804.83k shares per day over the last 10 days, according to various share statistics. A total of 50.32M shares are outstanding, with a floating share count of 46.36M. Insiders hold about 8.20% of the company’s shares, while institutions hold 105.24% stake in the company. Shares short for OM as of Mar 15, 2024 were 8.52M with a Short Ratio of 8.56, compared to 8.02M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 16.86% and a Short% of Float of 19.84%.
Earnings Estimates
Its stock is currently analyzed by 6 different market analysts. On average, analysts expect EPS of -$0.54 for the current quarter, with a high estimate of -$0.44 and a low estimate of -$0.62, while EPS last year was -$0.72. The consensus estimate for the next quarter is -$0.53, with high estimates of -$0.46 and low estimates of -$0.59.
Analysts are recommending an EPS of between -$1.95 and -$2.18 for the fiscal current year, implying an average EPS of -$2.06. EPS for the following year is -$1.8, with 6 analysts recommending between -$1.65 and -$1.99.
Revenue Estimates
6 analysts predict $30.45M in revenue for the current quarter. It ranges from a high estimate of $31M to a low estimate of $29.6M. As of the current estimate, Outset Medical Inc’s year-ago sales were $31.76M, an estimated decrease of -4.10% from the year-ago figure. For the next quarter, 6 analysts are estimating revenue of $33.71M, a decrease of -6.50% less than the figure of -$4.10% in the same quarter last year. There is a high estimate of $35.8M for the next quarter, whereas the lowest estimate is $32M.
A total of 7 analysts have provided revenue estimates for OM’s current fiscal year. The highest revenue estimate was $150.1M, while the lowest revenue estimate was $145.73M, resulting in an average revenue estimate of $148.42M. In the same quarter a year ago, actual revenue was $130.38M, up 13.80% from the average estimate. Based on 7 analysts’ estimates, the company’s revenue will be $173.92M in the next fiscal year. The high estimate is $179M and the low estimate is $165.7M. The average revenue growth estimate for next year is up 17.20% from the average revenue estimate for this year.
